TrialJAMA neurology2020

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.

Suzanne Craft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.